Cost effectiveness analysis of performing adjuvant therapy according to risk group and length of waiting list
| Risk group | Waiting list scenario | Gain in LE (months) | MCYLS (US$) |
|---|---|---|---|
| MCYLS, marginal cost per year of life saved. | |||
| Group 1 | 6 m | 2.2 | 74 728 |
| 12 m | 4.8 | 38 117 | |
| 18 m | 5.9 | 32 886 | |
| 24 m | 6.1 | 32 060 | |
| Group 2 | 6 m | 5.2 | 16 442 |
| 12 m | 6.5 | 12 489 | |
| 18 m | 6.7 | 10 911 | |
| 24 m | 6.4 | 10 086 | |